A leading pharma stock has gained significant attention following its successful fundraise of Rs.625 crore through the sale of shares to Citigroup and Societe Generale. This move is expected to strengthen the company’s financial position and support its growth plans, drawing investor focus to its strategic partnership with these global financial institutions.
Share Price Movement
In Tuesday’s trading session, Yatharth Hospital & Trauma Care Services Ltd’s share price rose by 2.5 percent, hitting an intra-day high of Rs.633.45 per share, up from the previous close of Rs.618.45 per share. The shares have since retreated and are trading at Rs.623.85 per share.
What is the News
Yatharth Hospitals Ltd. has successfully raised Rs.625 crore through a Qualified Institutional Placement (QIP) by issuing 1.05 crore equity shares to eligible institutional investors. The shares, with a face value of Rs.10 each, were priced at Rs.595 per share, reflecting a 5% discount to the floor price of Rs.626.
Notable domestic investors in the QIP include Kotak Mutual Fund (across various schemes), CitiGroup Global Markets, Societe Generale, and SBI Life Insurance.
Following the allotment of shares, the company’s paid-up equity share capital has increased from Rs.85.85 crore (8.58 crore shares) to Rs.96.35 crore (9.63 crore shares).
In a recent interview with CNBC-TV18, Yatharth Tyagi, a key figure at Yatharth Hospitals, expressed confidence that hospital occupancies would remain above 65 percent by FY2027, driven by growth from two hospitals that are still in their ramp-up phase.
Shareholding Pattern
According to the September 2024 shareholding pattern, the promoters hold a 66.54 percent stake in Yatharth Hospital & Trauma Care. Foreign Institutional Investors (FII) own 6.28 percent, while Domestic Institutional Investors (DII) and retail investors hold 6.98 percent and 20.20 percent, respectively.
Also read….
Financial Performance
In its recent financial updates, the company reported revenue of Rs.218 crore in Q2 FY25, marking a 27 percent growth from Rs.171 crore in Q2 FY24 and 3 percent from Rs.212 crore in Q4 FY24.
Similarly, the net profit of the company grew to Rs.31 crore from Rs.28 crore in the same period, reflecting an 11 percent increase. Moreover, quarterly the net profit increased 3 percent from Rs.30 crore in Q4 FY24.
Important Ratios
In terms of return ratios, return on capital employed (ROCE) stands at 17.21 percent, while return on equity (ROE) is at 13.86 percent. The company also features a strong current ratio of 8.02 and a low debt-to-equity ratio of 0.10.
Company Profile
Yatharth Hospital & Trauma Care Services Ltd is a prominent healthcare provider based in India, specifically in the National Capital Region (NCR), with a focus on delivering multi-specialty medical services. Here’s an overview of the hospital’s background, services, and operational details.
Written by – Siddesh S Raskar
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
